Kubota Pharmaceutical Holdings Co., Ltd.
KBBTF
Price:
$0.96
Market Cap:
$3.32B
Kubota Pharmaceutical Holdings Co., Ltd. operates globally, concentrating on the development of innovative drugs and medical devices within the ophthalmology sector. A key asset in its product pipeline is emixustat hydrochloride, which is currently undergoing Phase III clinical trials for Stargardt disease and Phase II trials for proliferative diabetic retinopathy. The company is also advancing a remote, patient self-monitoring optical coherence tomography (OCT) device designed for home use, intended to address conditions like wet age-related macular degeneration and diabetic macular edema, which are characterized by retinal swelling and reduced visual acuity. Furthermore, it is developing a...[Read more]
Industry
Medical - Devices
IPO Date
2017-06-19
Stock Exchange
OTC
Ticker
KBBTF
PE Ratio
[-2.30]
ROE
[-46.27%]
Current Ratio
[9.87]
Dividend Yield
[0%]
Enterprise Value
[1.55B]
Dividend History
The ROE as of June 2026 (TTM) for Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) is -46.27%
According to Kubota Pharmaceutical Holdings Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -46.27%. This represents a change of 280.25% compared to the average of -12.17% of the last 4 quarters.
Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) Historical ROE (quarterly & annually)
How has KBBTF ROE performed in the past?
The mean historical ROE of Kubota Pharmaceutical Holdings Co., Ltd. over the last ten years is -46.13%. The current -46.27% ROE has changed 0.31% with respect to the historical average. Over the past ten years (40 quarters), KBBTF's ROE was at its highest in in the September 2025 quarter at 0.84%. The ROE was at its lowest in in the December 2024 quarter at -23.97%.
Average
-46.13%
Median
-39.31%
Minimum
-95.91%
Maximum
-23.67%
Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) ROE by Quarter and Year
Discovering the peaks and valleys of Kubota Pharmaceutical Holdings Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 70.41%
Maximum Annual ROE = -23.67%
Minimum Annual Increase = -61.13%
Minimum Annual ROE = -95.91%
| Year | ROE | Change |
|---|---|---|
| 2025 | -37.28% | -61.13% |
| 2024 | -95.91% | 70.41% |
| 2023 | -56.28% | 10.26% |
| 2022 | -51.04% | -18.99% |
| 2021 | -63.00% | 54.91% |
| 2020 | -40.67% | 7.16% |
| 2019 | -37.95% | 31.35% |
| 2018 | -28.90% | 8.77% |
| 2017 | -26.56% | 12.25% |
| 2016 | -23.67% | 53.43% |
Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) Average ROE
How has KBBTF ROE performed in the past?
The current ROE of Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-63.16%
5-year avg
-60.70%
10-year avg
-46.13%
Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) ROE vs. Peers
How is KBBTF’s ROE compared to its peers?
Kubota Pharmaceutical Holdings Co., Ltd.’s ROE is greater than Mauna Kea Technologies S.A. (-58.93%), less than Chill Brands Group PLC (233.76%), less than Generation Hemp, Inc. (7.87%), greater than Renalytix Plc (-631.25%), greater than HS GovTech Solutions Inc. (-131.26%), less than PharmChem, Inc. (24.94%), less than OKYO Pharma Limited (102.92%), less than Kadimastem Ltd (0.12%), greater than U.S. NeuroSurgical Holdings, Inc. (-190.85%), greater than ImmuPharma plc (-1397.44%),
| Company | ROE | Market cap |
|---|---|---|
| -58.93% | $25.87M | |
| 233.76% | $24.45M | |
| 7.87% | $25.34M | |
| -631.25% | $22.55M | |
| -131.26% | $21.13M | |
| 24.94% | $21.95M | |
| 102.92% | $22.73M | |
| 0.12% | $9.50M | |
| -190.85% | $22.16M | |
| -1397.44% | $28.34M |
Build a custom stock screener for Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kubota Pharmaceutical Holdings Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Kubota Pharmaceutical Holdings Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Kubota Pharmaceutical Holdings Co., Ltd.'s ROE?
How is the ROE calculated for Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF)?
What is the highest ROE for Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF)?
What is the 3-year average ROE for Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF)?
What is the 5-year average ROE for Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF)?
How does the current ROE for Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) compare to its historical average?